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Abstract  
In this paper we investigated the antibacterial activity of a methanolic extract of Rosmarinus officinalis L. and their main constituents, carnosic acid and 
rosmarinic acid, against 37 nosocomial strains of multidrug-resistant bacteria. Results obtained showed that both the rosemary extract and carnosic acid 
inhibited all clinical isolates of Staphylococcus aureus methicillin-resistant and Enterococcus faecalis gentamicin and streptomycin-resistant bacteria 
examined (MICs 60 µg/mL vs. 200 µg/mL, respectively). Rosemary extract showed MIC values between 400 and 1600 µg/ml against the Gram-negative 
multidrug-resistant bacteria: Escherichia coli, Proteus mirabilis, Enterobacter cloacae, Pseudomonas aeruginosa, Morganella morganii and Providencia 
stuartii, while carnosic acid showed MIC of 120 to 240 µg/mL. Bactericidal effect of carnosic acid against S. aureus and E. faecalis was observed at their 
MIC value, while 2 x MIC to 4 x MIC were needed to kill Gram-negative bacteria. Rosmarinic acid showed a narrow spectrum of action against a few Gram-
negative clinical isolates. Our findings suggest that carnosic acid would be a good lead candidate useful in counteracting drug-resistant infections. 
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Resumen 
En este trabajo evaluamos la actividad antibacteriana de un extracto metanólico de Rosmarinus officinalis L. y sus principales componentes el ácido carnósico 
y ácido rosmarínico, contra 37 cepas de bacterias multirresistentes nosocomiales. Los resultados muestran que el extracto de romero y el ácido carnósico, 
inhibieron las bacterias Gram-positivas Staphylococcus aureus resistentes a meticilina y Enterococcus faecalis resistentes a gentamicina y estreptomicina 
(CIM 200 µg/mL y 60 µg/mL, respectivamente). El extracto de romero inhibió los Gram negativos multirresistentes: Escherichia coli, Proteus mirabilis, 
Enterobacter cloacae, Pseudomonas aeruginosa, Morganella morganii y Providencia stuartii (CIM 400 a 1600 µg/mL), mientras que el ácido carnósico 
mostró valores de CIM entre 120 a 240 µg/mL. El ácido carnósico mostró actividad bactericida contra S. aureus y E. faecalis a su CIM, mientras que  2 a 4 X 
CIM se requirieron para matar las bacterias Gram-negativas. El ácido rosmarínico mostró inhibió unos pocos aislados clínicos Gram-negativos. Estos 
hallazgos sugieren que el ácido carnósico puede ser de utilidad contra infecciones bacterianas  multirresistentes a antibióticos. 
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INTRODUCTION 
Rosemary (Rosmarinus officinalis L.) plants grow 
worldwide and have been cultivated since long ago for 
its strong antioxidant and antimicrobial activities. 
Nowadays, a long list of claims including 
antimicrobial, antioxidant, chemopreventive, and 
anticancer properties were described (Shahidi and 
Naczk, 2004; Barni et al., 2012). This species is 
considered to be one of the most important sources of 
both volatile and non-volatile bioactive compounds 
(Bradley, 2006). 
 The antimicrobial effect of rosemary extracts 
have been attributed to the high content of phenolic 
compounds including non-volatile components (Del 
Campo, 2000).  We previously reported the effective 
antimicrobial action of several non-volatile rosemary 
extracts containing 33 - 46% of diterpenes (carnosic 
acid plus carnosol) against common food pathogenic 
Gram positive bacteria as Staphylococcus aureus and 
Enterococcus faecalis as well as the Gram negative 
bacteria Escherichia coli,  which were all sensitive to 
antibiotics (Moreno et al., 2006). The methanol extract 
containing 30% of carnosic acid, 16% of carnosol and 
5% of rosmarinic acid was the most effective 
antimicrobial against Gram positive bacteria (minimal 
inhibition concentration, MIC, between 2 and 15 
µg/mL), Gram negative bacteria (MIC between 2 and 
60 µg/mL) and yeast (MIC of 4 µg/mL). By contrast, a 
water extract containing only 15% of rosmarinic acid 
showed a narrow activity. MIC values of the methanol 
and water extracts were in a good correlation with the 
values obtained using the commercial pure 
compounds, carnosic acid and rosmarinic acid, 
respectively. Therefore, carnosic acid and rosmarinic 
acid may be the main bioactive antimicrobial 
compounds present in these rosemary extracts 
(Moreno et al., 2006). Accordingly, a bioassay-guided 
fractionation of the leaf extract of R. officinalis led to 
the identification of carnosic acid and carnosol as the 
major compounds displaying the highest activity 
against oral pathogens as Streptococcus mutans, S. 
salivarius, S. sobrinus, S. mitis, S. sanguinis, and 
Enterococcus faecalis (Bernardes et al., 2010). In 
addition, carnosic acid was the major bioactive of 
commercial rosemary extract formulations having 
antimicrobial and antioxidant activity in vitro against 
gram-positive (Bacillus and Staphylococcus) and 
gram-negative (Campylobacter and Salmonella) 
bacteria (Klančnik et al., 2009).   
 In another work, we studied the antibacterial 
efficacy of an rosemary ethanolic extract containing a 
high amount of carnosic acid in two skin infection 
models in mice infected with an antibiotic sensitive 
strain of S. aureus (Barni et al., 2009). Results showed 
that this rosemary extract is able to carry out 
bactericide as well as bacteriostatic action comparable 
with the antibiotic action of the well-recognized 
antibiotic fusidic acid. Moreover, we found that 
carnosic acid showed a broad spectrum of 
pharmacological action as anti-inflammatory and 
anticarcinogenic (Mengoni et al., 2011; Barni et al., 
2012). Other researchers found that carnosic acid was 
active against a strain of S. aureus exhibiting 
multidrug-resistant efflux proteins with MIC values of 
16 to 60 µg/mL (Oluwatuyi et al., 2004) and in 
vancomycin-resistant enterococci (Horiuchi et al., 
2007). In this sense, recently we reported that carnosic 
acid showed a selective synergistic interaction with 
tetracycline and aminoglycosides in S. aureus ATCC 
25923 (Moreno et al., 2012). 
 The emergence of antibiotic resistance among 
both pathogenic and opportunistic microbes (S. aureus 
and E. faecalis) resident in hospitals represents a 
serious and recurrent problem for the treatment of 
infections (Hancock, 2005; Shepard and Gilmore, 
2002). Methicillin-resistant S. aureus (MRSA) can 
cause a multitude of diseases as a result of infection of 
various tissues of the body, its distribution is 
worldwide: as many as 11% - 40% of the population is 
estimated to be colonized and usually it shows 
resistance to many antibiotics. Bacterial resistance to 
β-lactam antibiotics has also risen dramatically 
(Paterson and Bonomo, 2005), contributing to this 
increase has been the spread of extended-spectrum β-
lactamase-producing bacteria that have spread 
worldwide by nosocomial routes. Treatment of the 
infections caused by these organisms is difficult, not 
only because of the resistance to the extended-
spectrum cephalosporin themselves, but also because 
they are often associated with resistance to other 
antimicrobial agents coded either by the same or 
different plasmids. The progress of resistance to the 
last line of antibiotic defense has led to the search of 
new antibiotics and nowadays natural drugs could 
represent a remarkable approach to limit the 
emergence and spread of multi-drug resistant 
organisms (Lewis and Ausubel, 2006; Smith et al., 
2007). 
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 Therefore, although it has been reported that 
non-volatile rosemary compounds have antimicrobial 
properties against antibiotic sensitive microorganisms, 
little information exists regarding their efficacy as 
microbicide against multidrug-resistant bacteria. This 
contribution reports the efficacy and potency of non-
volatile rosemary constituents, carnosic and rosmarinic 
acid, against several multi-drug resistance Gram-
positive and Gram-negative strains isolated from a 
Hospital in Argentina.  
 
MATERIALS AND METHODS  
Materials 
All solvents used in the experiments were purchased 
from Merck (USA). Carnosic acid (Sigma, Aldrich 
Lot #061M1862v) and rosmarinic acid (Extrasynthase 
Lot #08041513, Genay, France). All other reagents 
were of analytical grade.  
 
Preparation and analysis of rosemary extract 
The methanol rosemary extract used in this study was 
prepared as previously reported (Moreno et al., 2006). 
Briefly, dried rosemary leaves (20 - 200 g) were 
chopped into small parts with a blender and placed in a 
3L round-bottom flask with 1L of deionized water. 
The solution was steam-distilled for 60 min in a 
Clevenger-type apparatus for oil isolation. The residue 
was extracted using methanol as solvent by a Soxhlet 
apparatus. The solvent was vacuum-distilled at 37° C 
in a rotary evaporator. The final extract was a dark 
green powder, and it was kept in a freezer at -20° C 
until use. The content of carnosic acid, and rosmarinic 
acid of the extract was analyzed by high-performance 
liquid chromatography (HPLC). The extract was 
resuspended in pure methanol and centrifuged using a 
5804 Eppendorf centrifuge at 5000 rpm for 15 min at 
room temperature before analysis. HPLC was 
performed with an LKB Bromma instrument equipped 
with a diode array detector, using a 250 mm x 4 mm 
C18 Luna analytical column (Phenomenex, USA). The 
separation was undertaken with a mobile phase 
consisting of a gradient of 5 - 100% acetonitrile in 
water containing 3% (v/v) acetic acid at a flow rate of 
1 mL/min and the injection volume was 20 µL. 
Different criteria were developed for compound 
identification such as comparison of the retention time 
using commercial standards, determination of 
maximum absorbance at different wavelengths for 
compounds, UV spectra using a photo-diode array 
detector and by adding pure standards to the samples 
prior to HPLC analysis.  
 The methanol rosemary extract contained 33 - 
46% of diterpens (carnosic acid plus carnosol) and 5% 
of rosmarinic acid determined by high-performance 
liquid chromatography according to Moreno et al., 
2006. The extract was kept in a freezer at -20° C until 
use. Stock solutions of pure carnosic acid, and 
rosmarinic acid (1 mg/mL) were prepared in ethanol. 
 
Bacterial strains 
The microorganisms used in this study consisted of 
bacterial isolates collected from clinical samples 
obtained from the Hospital Nicolás Avellaneda, 
Tucumán, Argentina: S. aureus (n = 7), E. faecalis (n 
= 13), E. coli (n = 7), E. cloacae (n = 4), P. mirabilis 
(n = 3), P. aeruginosa  (n = 1), Morganella morganii 
(n = 1) and Providencia stuartii (n = 1). S. aureus 
ATCC 25923 and E. faecalis ATCC 29212 were also 
included in the investigation. All samples were 
identified by standard methods according to the 
recommendations of the Manual of Clinical 
Microbiology (Murray et al., 1999) and the CLSI 
guidelines, 2007. Resistance to antibiotics was 
determined as previously described (Arias et al., 2004; 
Zampini et al., 2005). The strains were maintained in 
brain-heart infusion broth containing 30% (v/v) 
glycerol at -20° C. Before testing, the suspensions 
were transferred to trypticase soy agar supplemented 
with 5% of sheep blood (Difco) and aerobically grown 
overnight at 35° C. Individual colonies were isolated 
and suspended in 5 mL of 0.9% NaCl solution. The 
inoculums were prepared by adjusting the turbidity of 
the suspension to match the 0.5 McFarland and diluted 
in cation-adjusted Müller Hinton broth (Difco, MD, 
USA).   
 
Antibacterial activity 
Serial agar macrodilution method was used to measure 
the antibacterial activity against clinical isolate strains 
as previously described (Zampini et al., 2005). Müller 
Hinton Agar (MHA) (9 mL) was mixed with 1 mL of 
serial dilutions of carnosic acid and rosmarinic acid 
performed with ethanol at a final concentration of 15 - 
480 μg/mL or with the methanol rosemary extract at a 
final concentration of 15 - 1600 μg/mL. Then, plates 
were inoculated with 2 μL of each bacterial cell 
suspension (5×10
4
 CFU/mL) and aerobically 
incubated for 18 h at 35° C. A growth control of each 
tested strain was included. MIC values were defined as 
the lowest concentration of compounds or antibiotics 
where no colony was observed after incubation. 
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 The broth microdilution method has been used 
in a microtiter plate-based assay according to the 
National Clinical Laboratory Standard (CLSI, 2007) 
recommendations. The Müller-Hinton medium 
containing carnosic acid and rosmarinic acid (15 - 800 
μg/mL) was dispensed at 100 μL/well in 96-well 
microtiter sterile plate. Each well was inoculated with 
10 μL of bacterial culture (1x 105 CFU/mL). The 
plates were incubated at 37º C for 20 h with agitation 
at 200 rpm and the bacterial growth was monitored by 
absorbance at 595 nm in a microtiter plate reader 
(Beckman Coulter DTX880 Multimode Detector). All 
experiments were performed in three independent 
times and each sample assayed in triplicate. The 
antibacterial activity was expressed as the minimal 
inhibitory concentration (MIC) of compounds that will 
inhibit the visible growth of bacteria alone. The 
minimum bactericide concentration (MBC) was the 
lowest concentration of the substance at which 
survival of any bacterial cell was not possible after 
incubation for 48 h and was determined by inoculating 
on agar plates a portion of the broth culture, where 
MIC values were previously defined. 
 
RESULTS  
We used the methanol rosemary extract to perform 
this study since it was the more efficient as 
antibacterial against several Gram-positive and Gram-
negative bacteria and yeast all sensible to antibiotics 
(Moreno et al., 2006).  Here, this rosemary extract 
rich in carnosic acid and the main pure constituents, 
carnosic acid and rosmarinic acid were evaluated 
against MRSA and E. faecalis multi  drug-resistant 
strains isolated from a Hospital in Argentina (Table 
1). The rosemary extract inhibited the growth of 
MRSA with a MIC value of 200 μg/mL. Similar result 
was obtained for the ATCC strain. Carnosic acid was 
active against MRSA with a MIC value of 60 µg/mL. 
Rosmarinic acid was ineffective even at high 
concentration as 480 μg/mL. Table 1 also presented 
the antibacterial activity of the rosemary extract as 
well as carnosic acid and rosmarinic acid against 
thirteen strains of E. faecalis resistant to gentamicin, 
streptomycin or to strains exhibiting dual resistance 
isolated from the Hospital. The plant extract showed a 
MIC value of 200 to 400 μg/mL against multidrug-
resistant as well as sensitive bacteria. Carnosic acid 
was also able to inhibit the growth of these pathogenic 
strains at a concentration of 60 µg/mL. Rosmarinic 
acid was inactive against these bacterial strains even at 
high concentration as 480 μg/mL. 
Table 2 shows the minimal bactericide 
concentration of the rosemary extract at 2 × MIC to 4 
× MIC and carnosic acid at the MIC value against S. 
aureus and E. faecalis strains. Notably, carnosic acid 
inhibited both antibiotic-resistant as well as sensitive 
bacteria at the same concentration. 
Carnosic acid was also active against all the 
multidrug-resistant Gram-negative bacteria tested 
Table 3. This compound was particularly active 
towards E. cloacae 302 strain expressing extended-
spectrum β-lactamases resistant to levofloxacine, 
piperazilina/tazobactam, ceftriaxome, cefotaxime, 
cefuroxima, ampicillin/sulbactam and meropenem as 
well as against P. mirabilis 304 resistant to 
cefuroxima, ampicillin/sulbactam and meropenem 
with a MIC of 30 µg/mL and 60 µg/mL, respectively. 
However, a lower efficacy of carnosic acid against E. 
coli, E. cloacae and P. mirabilis strains was observed 
with MIC values of 120 µg/ml to 240 µg/mL. 
  Rosmarinic acid exhibited a narrowly spectra 
of antibacterial action inhibiting the ß-lactamase–
producing P. mirabilis 304 and 359 strains, as well the 
multidrug-resistant P. aeruginosa strain with MIC 
values of 120 µg/mL, while it was ineffective against 
the other bacteria at high concentration as 480 μg/mL 
(Table 3). 
 
DISCUSSION 
The activity of the rosemary extract against the human 
Gram-positive bacteria, which exhibited bactericidal 
activity at 60 µg/mL, seems to be related to the 
presence of carnosic acid, while the other constituents 
of the extract, rosmarinic acid, was inactive. Carnosic 
acid showed the broadest spectrum of action inhibiting 
all the Gram-positive and Gram-negative clinical 
strains tested. These results are in accord with 
previously suggestion that carnosic acid was the major 
bioactive compounds of the rosemary extract 
exhibiting antimicrobial activity (Moreno et al., 
2006).  
It is important to note that carnosic acid is 
active toward extended-spectrum β-lactamases strains, 
which are capable of hydrolyzing penicillins, broad-
spectrum cephalosporins and monobactams (Morosini 
et al., 2006; Paterson and Bonomo, 2005). Therefore, 
carnosic acid may be a valuable alternative to 
imipenem and meropenem to treat infections with 
these organisms. The antibacterial potency of carnosic 
acid observed in this study against clinical isolates of 
multidrug-resistant bacteria is comparable with the 
activity reported for other phenolic diterpene isolated 
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from plants as the terpene totarol and the alkaloid 
reserpine (Gibbons and Udo, 2000; Otsuka et al., 
2008).  
 
Table 1 
Antibacterial activity of the rosemary extract (RE) and carnosic acid (CA) against multidrug resistant 
Gram-positive bacteria Staphylococcus aureus and Enterococcus faecalis 
 
Bacterial 
strains
 
 
 
Fenotype of 
clinical isolates
 
 
MIC  
(μg/mL) 
RE      CA 
 
 
RA 
S. aureus 
F 01 
 
MET
R
OXA
R
GEN
R
 
 
200 
 
60 
 
n.a. 
F 02 MET
R
OXA
R
GEN
R
 200 60 n.a. 
F 03 MET
R
OXA
R
GEN
R
 200 60 n.a. 
F 05 MET
R
OXA
R
GEN
R
 200 60 n.a. 
F 07 MET
R
OXA
R
GEN
R
 200 60 n.a. 
F 08 MET
R
OXA
R
GEN
R
 200 60 n.a. 
F 23 MET
R
OXA
R
GEN
R
 200 60 n.a. 
ATCC 25923 MET
S
OXA
S
GEN
S
  200 60 n.a. 
E. faecalis     
F 202 GEN
S
STR
S
 200 60 n.a. 
F 203 GEN
R
STR
R 
 200 60 n.a. 
F 204 GEN
R
STR
S
 200 60 n.a. 
F 205 GEN
R
STR
R 
 200 60 n.a. 
F 210 GEN
S
STR
 R
 200 60 n.a. 
F 217 GEN
S
STR
R 
 200 60 n.a. 
F 218 GEN
R
STR
R 
 200 60 n.a. 
F 222 GEN
R
STR
S
 200 60 n.a. 
F 228 GEN
S
STR
R 
 200 60 n.a. 
F 231 GEN
S
STR
S
 200 60 n.a. 
F 242 GEN
S
STR
R
 200 60 n.a. 
F 253 GEN
S
STR
S
 200 60 n.a. 
F 256 GEN
S
STR
R
 200 60 n.a. 
ATCC 29212 GEN
S
STR
S
 200 60 n.a. 
MET, methicillin; GEN, gentamicin; OXA, oxacillin, STR, streptomycin. R: Resistance. S: Sensitive.   
n.a.: no active until 480 μg/mL. 
 
Regarding the antibacterial activity of 
rosmarinic acid, earlier we reported that this ester of 
caffeic acid is active only against S. aureus sensitive 
to antibiotics (Moreno et al., 2006). In this work, this 
compound is inactive against all the MRSA tested. 
However, the Gram-negative bacteria P. mirabilis, P. 
aeruginosa, P. stuartii and M. morganii strains 
showed some sensitivity to the rosmarinic acid. 
According to these results, rosmarinic acid inhibited 
the growth of planktonic cells of P. aeruginosa 
(Walker et al., 2004). 
In general Gram-positive bacteria were found 
to be more sensitive to the hydrophobic plant 
compounds than the Gram-negative bacteria (Burt, 
2004). Nevertheless, our results showed that the 
lipophilic carnosic acid is able to inhibit the growth of 
both Gram-negative and Gram-positive clinical strains 
with a comparable potency. Although the exact 
antibacterial mechanism of carnosic acid is not fully 
known, we reported recently that this compound can 
function as an efflux pump modulator by dissipation 
of the membrane potential (Moreno et al., 2012). 
Inside the rosemary plants this diterpene has been 
found associated with chloroplasts membranes (Perez-
Fons et al., 2010).  
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Table 2 
Minimal bactericide concentration (MBC) of the rosemary extract (RE) and carnosic acid (CA) against S. 
aureus and E.  faecalis strains 
 
Bacterial strains 
 
MBC  
(μg/mL) 
RE            CA 
S. aureus  
F 05 
F 07 
 ATCC 25923 
E. faecalis 
 
800 
800 
200 
 
60 
60 
60 
 
F 202 200 60 
F 204 400 60 
F 205 800 60 
F 210 800 60 
F 218 400 60 
F 222 400 60 
F 231 400 60 
ATCC 29212 400 60 
 
 
 
 
 
All together, the available evidence indicates 
that rosemary compounds might be of therapeutic 
value against multidrug-resistant bacterial infections. 
Carnosic acid is a potential antibacterial agent which 
exhibited a moderate activity against several 
multidrug-resistant Gram-positive and Gram-negative 
bacteria. A future therapeutic challenge is needed to 
demonstrate its in vivo efficacy and the possibility to 
use this compound in combinational therapies. 
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Table 3 
Antibacterial activity of rosemary extract (RE), carnosic acid (CA) and rosmarinic acid (RA) against Gram-
negative multidrug-resistant strains 
 
 
LEV, levofloxacine; CRO, ceftriaxone; CTX, cefotaxime; CXM, cefuroxime; SAM, ampicillin/sulbactam; 
MEM, meropenem; TZP, piperacyline/tazobactam; CAZ, ceftazidime; FEP, cefepime; AMK, amikacin; 
IPM, imipenem. R: Resistance. S: Sensitive.  n.a: no active until 480 μg/mL. 
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Bacterial strains Phenotype of clinical isolates
 
 MIC (μg/mL) 
RE          CA 
 
RA 
Escherichia coli  
F 301 
 
LEV
R
CRO
R
CTX
R
CXM
R
SAM
R
MEM
R
TZP
S
CAZ
S
FEP
S
 
 
           400 
 
120 
 
n.a. 
F 306 LEV
S
CRO
R
CTX
R
CXM
R
SAM
R
MEM
R
TZP
S
CAZ
S
FEP
R
 1600 240 n.a 
F 330 LEV
R
CRO
R
CTX
R
CXM
R
SAM
R
MEM
R
TZP
S
CAZ
S
FEP
S
 1600 240 n.a 
F 331 LEV
R
CRO
R
CTX
R
CXM
R
SAM
R
MEM
R
TZP
R
CAZ
R
FEP
R
 1600 120 n.a 
F 345 LEV
R
CRO
R
CTX
R
CXM
R
SAM
R
MEM
R
TZP
S
CAZ
S
FEP
S
 1600 240 n.a 
F 348 LEV
R
CRO
R
CTX
R
CXM
R
SAM
R
MEM
R
TZP
S
CAZ
S
FEP
S
 1600 240 n.a 
F 350 LEV
R
CRO
R
CTX
R
CXM
R
SAM
R
MEM
R
TZP
R
CAZ
S
FEP
R
 1600 240 n.a 
Enterobacter cloacae 
F 302 
 
LEV
R
CRO
R
CTX
R
CXM
R
SAM
R
MEM
R
TZP
R
CAZ
S
FEP
R
 
 
400 
   
30 
 
n.a. 
F 308 LEV
S
CRO
S
CTX
R
CXM
R
SAM
R
MEM
R
TZP
S
CAZ
R
FEP
R
 800 120 n.a. 
F 326 LEV
S
CRO
S
CTX
S
CXM
R
SAM
S
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